Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 390 of 6351
-
Can a biologic drug help peanut allergy sufferers tolerate nuts?
Disease control Recruiting nowThe proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy (OIT) for the treatment of peanut allergy. Study participation is divided into 3 periods: (…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for recurrent glioblastoma: experimental drug LMP744 enters human trials
Disease control Recruiting nowBackground: Glioblastoma is a common brain cancer in adults. Treatment includes surgery, radiation, and chemotherapy. But this cancer can return after treatment and is often fatal. Researchers want to know if a study drug (LMP744) can kill glioblastoma tumor cells. Objective: …
Phase 1/2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New heart valve device aims to fix leaky valve without open surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn if LuX-Valve Plus system works to treat symptomatic subjects with at least severe tricuspid regurgitation (TR). It will also learn about the safety of LuX-Valve Plus system. Researchers will compare LuX-Valve Plus system to a conventio…
Sponsor: Jenscare Innovation Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis phase 1 study evaluates the safety, efficacy, and biological activity of GB-5267 in patients with platinum-resistant ovarian cancer.
Phase 1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Gene therapy hope for kids with rare citrate disorder
Disease control Recruiting nowPhase 1/2, open-label study to assess the efficacy and safety of a single lumbar intrathecal administration of TSHA-105 in individuals with SLC13A5 Citrate Transporter Disorder
Phase 1/2 • Sponsor: TESS Research Foundation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
App to prevent postpartum depression tested on 3,000 women
Prevention Recruiting nowThis study is part of the ERC-funded e-Perinatal project and represents a large-scale hybrid type 1 effectiveness-implementation cluster randomized controlled trial. The primary aim is to evaluate the effectiveness of a personalized and complex mobile health (mHealth) interventio…
Sponsor: University of Seville • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Could poop transplants save sepsis patients?
Disease control Not yet recruitingSepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, representing one of the leading causes of death in intensive care units (ICUs) worldwide. Gut microbiota disruption is increasingly recognized as a key driver of persistent inflamm…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could tailoring chemo by age make stem cell transplants safer for MDS patients?
Disease control Not yet recruitingThis study plan aims to enroll adult patients diagnosed with myelodysplastic syndrome (MDS) who are scheduled to receive T-cell-replete haploidentical hematopoietic stem cell transplantation. After obtaining written informed consent, participants will receive either reduced-toxic…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to tame rare nerve disease
Disease control Not yet recruitingThis clinical trial aims to evaluate the safety and efficacy of ripertamab in patients with neuromyelitis optica spectrum disorders (NMOSD). The key research objectives are as follows: 1. To assess the efficacy of ripertamab for the treatment of neuromyelitis optica spectrum dis…
Phase 1/2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI could spot hidden stroke type that often worsens quickly
Diagnosis Recruiting nowBranch atheromatous disease (BAD)-related stroke is an important subtype of acute ischemic stroke involving penetrating arteries and is associated with early neurological deterioration. Early recognition and standardized diagnosis remain challenging in routine clinical practice b…
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could a simple questionnaire spot colorectal cancer before It's too late?
Knowledge-focused Not yet recruitingThis is a multicenter, observational study designed to develop and validate a diagnostic model for colorectal cancer and advanced colorectal neoplasia among adults undergoing routine-care colonoscopy in the Chinese population. The study will enroll adults aged 18 to 80 years who…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New drug cocktail aims to stop Chemo-Linked nausea before it starts
Symptom relief Not yet recruitingThis study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New mRNA vaccine aims to shield against RSV
Vaccine Not yet recruitingA Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection
Phase 1 • Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. • Aim: Vaccine
Last updated Jul 12, 2026 00:00 UTC
-
Can a smaller incision for kidney stone surgery reduce recovery without sacrificing results?
Disease control Recruiting nowKidney stones that are large or complex are often treated with percutaneous nephrolithotomy, also called PCNL. Standard PCNL uses a larger access tract and is effective for removing complex kidney stones, but it may be associated with more bleeding, pain, and recovery burden. Mod…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a single surgery replace daily eye drops for glaucoma?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether doing phacoemulsification combined with gonioscopy-assisted trabeculotomy as an initial treatment can reduce the burden of glaucoma eye drops in adults with primary open-angle glaucoma and cataract. It will also learn whether th…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
Disease control Recruiting nowThis is a multicenter, open-label, Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of domatinostat in combination with sirolimus in adolescents and adults with relapsed or refractory sarcoma and osteosarcoma.
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Brain waves may foretell stroke recovery
Knowledge-focused Not yet recruitingThis is a single-center, prospective, observational cohort study that plans to consecutively enroll 400 patients with acute ischemic stroke from July 2026 to July 2029. The study will not interfere with acute-phase treatment decisions; information on reperfusion and non-reperfusi…
Sponsor: Xuanwu Hospital, Beijing • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Which knee surgery approach gets you back on your feet faster?
Disease control Not yet recruitingThis study aims to compare the effects of the medial parapatellar approach (MP) and the subvastus approach (SV) on postoperative clinical function in total knee arthroplasty (TKA). A total of 84 patients, who visit the Joint Surgery Department of Peking University Third Hospital …
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a phone app teach the brain to read social cues?
Symptom relief Recruiting nowThe purpose of this study is to evaluate the safety and preliminary effectiveness of a smartphone-based digital therapeutic application (AffectUs) for improving social cognition, particularly emotion processing and social cue perception, in individuals with schizophrenia spectrum…
Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can herbal plasters boost chemo nausea relief?
Symptom relief Recruiting nowThis single-center, randomized, controlled study evaluates whether acupoint application added to standard 5-HT3 receptor antagonist anti-nausea medication improves control of chemotherapy-induced nausea and vomiting in adults with lung cancer receiving first-line platinum-based c…
Sponsor: Xiu Huang • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC